相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Site-Specific Phosphorylation of Huntingtin Exon 1 Recombinant Proteins Enabled by the Discovery of Novel Kinases
Anass Chiki et al.
CHEMBIOCHEM (2021)
A Chain of Events: Regulating Target Proteins by SUMO Polymers
Nicolette S. Jansen et al.
TRENDS IN BIOCHEMICAL SCIENCES (2021)
PIAS1 modulates striatal transcription, DNA damage repair, and SUMOylation with relevance to Huntington's disease
Eva L. Morozko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Altered Gut Microbiota Related to Inflammatory Responses in Patients With Huntington's Disease
Gang Du et al.
FRONTIERS IN IMMUNOLOGY (2021)
Involvement of the Protein Ras Homolog Enriched in the Striatum, Rhes, in Dopaminergic Neurons' Degeneration: Link to Parkinson's Disease
Marcello Serra et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Huntingtin and the Synapse
Jessica C. Barron et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2021)
Targeting SUMO Signaling to Wrestle Cancer
Jessie S. Kroonen et al.
TRENDS IN CANCER (2021)
Post-translational modifications in proteins: resources, tools and prediction methods
Shahin Ramazi et al.
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2021)
SUMOylation in Neurodegenerative Diseases
Andrea Princz et al.
GERONTOLOGY (2020)
SUMOylation Prevents Huntingtin Fibrillization and Localization onto Lipid Membranes
Faezeh Sedighi et al.
ACS CHEMICAL NEUROSCIENCE (2020)
Molecular mechanisms in SUMO conjugation
Nathalia Varejao et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2020)
Sumoylation on its 25th anniversary: mechanisms, pathology, and emerging concepts
Arda B. Celen et al.
FEBS JOURNAL (2020)
Do Post-Translational Modifications Influence Protein Aggregation in Neurodegenerative Diseases: A Systematic Review
Larissa-Nele Schaffert et al.
BRAIN SCIENCES (2020)
Loss of Hap1 selectively promotes striatal degeneration in Huntington disease mice
Qiong Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Evaluation of post-translational modifications in histone proteins: A review on histone modification defects in developmental and neurological disorders
Shahin Ramazi et al.
JOURNAL OF BIOSCIENCES (2020)
Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities
Sarah J. Tabrizi et al.
NATURE REVIEWS NEUROLOGY (2020)
Deciphering protein post-translational modifications using chemical biology tools
Anne C. Conibear
NATURE REVIEWS CHEMISTRY (2020)
SUMO proteins in the cardiovascular system: friend or foe?
Prithviraj Manohar Vijaya Shetty et al.
JOURNAL OF BIOMEDICAL SCIENCE (2020)
Inflammation in Huntington's disease: A few new twists on an old tale
Priscila Aparecida Costa Valadao et al.
JOURNAL OF NEUROIMMUNOLOGY (2020)
Huntington disease: A quarter century of progress since the gene discovery
Claudia M. Testa et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2019)
A role for autophagy in Huntington's disease
Katherine R. Croce et al.
NEUROBIOLOGY OF DISEASE (2019)
Rhes travels from cell to cell and transports Huntington disease protein via TNT-like protrusion
Manish Sharma et al.
JOURNAL OF CELL BIOLOGY (2019)
Health state utility values (QALY weights) for Huntington's disease: an analysis of data from the European Huntington's Disease Network (EHDN)
Annie Hawton et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2019)
Huntington's disease: a clinical review
P. McColgan et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Regulation of HSF1 protein stabilization: An updated review
Chao Huang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
The Thyroid Hormone-target Gene Rhes a Novel Crossroad for Neurological and Psychiatric Disorders: New Insights from Animal Models
Francesco Napolitano et al.
NEUROSCIENCE (2018)
An overview of the possible therapeutic role of SUMOylation in the treatment of Alzheimer's disease
S. Marcelli et al.
PHARMACOLOGICAL RESEARCH (2018)
SUMO-Targeted Ubiquitin Ligases (STUbLs) Reduce the Toxicity and Abnormal Transcriptional Activity Associated With a Mutant, Aggregation-Prone Fragment of Huntingtin
Kentaro Ohkuni et al.
FRONTIERS IN GENETICS (2018)
Increased SUMO-2/3-ylation mediated by SENP3 degradation is protective against cadmium-induced caspase 3-dependent cytotoxicity
Jia Luo et al.
JOURNAL OF TOXICOLOGICAL SCIENCES (2017)
Transcriptional profiles for distinct aggregation states of mutant Huntingtin exon 1 protein unmask new Huntington's disease pathways
Nagaraj S. Moily et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2017)
Body Weight Is a Robust Predictor of Clinical Progression in Huntington Disease
Jorien M. M. van der Burg et al.
ANNALS OF NEUROLOGY (2017)
Neuropsychiatric Burden in Huntington's Disease
Ricardo Augusto Paoli et al.
BRAIN SCIENCES (2017)
Battling Alzheimer's Disease: Targeting SUMOylation-Mediated Pathways
Wagner Carbolin Martins et al.
NEUROCHEMICAL RESEARCH (2016)
SUMO-regulated mitochondrial function in Parkinson's disease
Ana Cristina Guerra de Souza et al.
JOURNAL OF NEUROCHEMISTRY (2016)
PIAS1 Regulates Mutant Huntingtin Accumulation and Huntington's Disease-Associated Phenotypes In Vivo
Joseph Ochaba et al.
NEURON (2016)
The interrelationship of proteasome impairment and oligomeric intermediates in neurodegeneration
Jennifer M. Deger et al.
AGING CELL (2015)
Ectopic expression of the striatal-enriched GTPase Rhes elicits cerebellar degeneration and an ataxia phenotype in Huntington's disease
Supriya Swarnkar et al.
NEUROBIOLOGY OF DISEASE (2015)
Cellular maintenance of nuclear protein homeostasis
Pamela S. Gallagher et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
The role of Rhes, Ras homolog enriched in striatum, in neurodegenerative processes
Laura M. Harrison et al.
EXPERIMENTAL CELL RESEARCH (2013)
SUMO-1 is Associated with a Subset of Lysosomes in Glial Protein Aggregate Diseases
Mathew B. Wong et al.
NEUROTOXICITY RESEARCH (2013)
SUMO-2 and PIAS1 Modulate Insoluble Mutant Huntingtin Protein Accumulation
Jacqueline Gire O'Rourke et al.
CELL REPORTS (2013)
Suppression of protein aggregation by chaperone modification of high molecular weight complexes
John Labbadia et al.
BRAIN (2012)
Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease
Ulziibat P. Shirendeb et al.
HUMAN MOLECULAR GENETICS (2012)
Biological markers of cognition in prodromal Huntington's disease: A review
Kathryn V. Papp et al.
BRAIN AND COGNITION (2011)
Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases
P. Hemachandra Reddy et al.
BRAIN RESEARCH REVIEWS (2011)
The regulation of mitochondrial morphology: Intricate mechanisms and dynamic machinery
Catherine S. Palmer et al.
CELLULAR SIGNALLING (2011)
Huntington's Disease is a disorder of the corpus striatum: Focus on Rhes (Ras homologue enriched in the striatum)
Srinivasa Subramaniam et al.
NEUROPHARMACOLOGY (2011)
Small Changes, Big Impact: Posttranslational Modifications and Function of Huntingtin in Huntington Disease
Dagmar E. Ehrnhoefer et al.
NEUROSCIENTIST (2011)
Does Huntingtin play a role in selective macroautophagy?
Joan S. Steffan
CELL CYCLE (2010)
Rhes, a Physiologic Regulator of Sumoylation, Enhances Cross-sumoylation between the Basic Sumoylation Enzymes E1 and Ubc9
Srinivasa Subramaniam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The role of post-translational modifications of huntingtin in the pathogenesis of Huntington's disease
Yan Wang et al.
NEUROSCIENCE BULLETIN (2010)
IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome
Leslie Michels Thompson et al.
JOURNAL OF CELL BIOLOGY (2009)
SUMOylation and deSUMOylation at a glance
Yonggang Wang et al.
JOURNAL OF CELL SCIENCE (2009)
Beyond the brain: widespread pathology in Huntington's disease
Jorien M. M. van der Burg et al.
LANCET NEUROLOGY (2009)
Huntington disease: pathogenesis, biomarkers, and approaches to experimental therapeutics
Christopher A. Ross et al.
PARKINSONISM & RELATED DISORDERS (2009)
Rhes, a Striatal Specific Protein, Mediates Mutant-Huntingtin Cytotoxicity
Srinivasa Subramaniam et al.
SCIENCE (2009)
A caspase-3-cleaved fragment of the glial glutamate transporter EAAT2 is sumoylated and targeted to promyelocytic leukemia nuclear bodies in mutant SOD1-linked amyotrophic lateral sclerosis
Stuart L. Gibb et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
SUMO on the road to neurodegeneration
Veronique Dorval et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Human cystathionine β-synthase is a target for sumoylation
Omer Kabil et al.
BIOCHEMISTRY (2006)
SUMO modification of Huntingtin and Huntington's disease pathology
JS Steffan et al.
SCIENCE (2004)
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
M Arrasate et al.
NATURE (2004)
SUMO-1 marks the nuclear inclusions in familial neuronal intranuclear inclusion disease
DL Pountney et al.
EXPERIMENTAL NEUROLOGY (2003)
SUMO-1 co-localized with mutant atrophin-1 with expanded polyglutamines accelerates intranuclear aggregation and cell death
T Terashima et al.
NEUROREPORT (2002)
Enhanced SUMOylation in polyglutamine diseases
H Ueda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
分享论文
